Synbiotics, Prebiotics, Glutamine, or Peptide in Early Enteral Nutrition: A Randomized Study in Trauma Patients

Journal of Parenteral and Enteral Nutrition - Tập 31 Số 2 - Trang 119-126 - 2007
Alenka Spindler‐Vesel1, Stig Bengmark2, Irena Vovk3, Ognjen Cerović1, Lidija Kompan1
1University Medical Centre Ljubljana, Slovenia
2Departments of Hepatology and Surgery, University College London, London University, England
3National Institute of Chemistry, Ljubljana, Slovenia

Tóm tắt

Background: Since the hepatosplanchnic region plays a central role in development of multiple‐organ failure and infections in critically ill trauma patients, this study focuses on the influence of glutamine, peptide, and synbiotics on intestinal permeability and clinical outcome. Methods: One hundred thirteen multiple injured patients were prospectively randomized into 4 groups: group A, glutamine; B, fermentable fiber; C, peptide diet; and D, standard enteral formula with fibers combined with Synbiotic 2000 (Synbiotic 2000 Forte; Medifarm, Sweden), a formula containing live lactobacilli and specific bioactive fibers. Intestinal permeability was evaluated by measuring lactulose‐mannitol excretion ratio on days 2, 4, and 7. Results: No differences in days of mechanical ventilation, intensive care unit stay, or multiple‐organ failure scores were found between the patient groups. A total of 51 infections, including 38 pneumonia, were observed, with only 5 infections and 4 pneumonias in group D, which was significantly less than combined infections (p = .003) and pneumonias (p = .03) in groups A, B, and C. Intestinal permeability decreased only in group D, from 0.148 (0.056–0.240) on day 4 to 0.061 (0.040–0.099) on day 7; (p < .05). In group A, the lactulose‐mannitol excretion ratio increased significantly (p < .02) from 0.050 (0.013–0.116) on day 2 to 0.159 (0.088–0.311) on day 7. The total gastric retention volume in 7 days was 1150 (785–2395) mL in group D, which was significantly more than the 410 (382–1062) mL in group A (p < .02), and 620 (337–1190) mL in group C (p < .03). Conclusions: Patients supplemented with synbiotics did better than the others, with lower intestinal permeability and fewer infections.

Từ khóa


Tài liệu tham khảo

10.1097/00005373-199604000-00009

Sautner T, 1995, Tumour necrosis factor‐alpha and interleukin‐6: early indicators of bacterial infection after human orthotopic liver transplantation, Eur J Surg., 161, 97

10.1097/00075198-200104000-00007

10.1097/00024382-200206000-00009

10.1097/00003246-200003000-00007

10.1097/00003246-199503000-00006

10.1007/s00134-003-1711-5

10.1001/jama.286.8.944

10.1007/s001340000703

10.1097/00000658-200107000-00014

10.1097/00024382-200116050-00014

10.1097/00003246-200209000-00011

Felippe Junior J, 1993, Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1–3 polyglucose (glucan), Surg Gynecol Obstet., 177, 383

10.1016/S0899-9007(02)00811-0

10.1097/00007890-200207150-00021

10.1046/j.1365-2168.2002.02189.x

10.1007/s00423-003-0425-z

10.1007/s001340050809

Knight DJW, 2004, The effect of synbiotics on gastrointestinal flora in the critically ill, Br J Anaesth, 92, 307

10.1097/00005373-197403000-00001

Kruszewska D, 2002, Selection of lactic acid bacteria as probiotic strains by in vitro tests, Microecol Ther., 29, 37

10.1080/089106002760003279

Seneff M, 1989, APACHE: a prognostic scoring system, Probl Crit Care, 3, 563

10.1001/archsurg.1985.01390340007001

10.1556/JPC.16.2003.5.8

10.1016/0196-6553(88)90053-3

10.1378/chest.120.3.955

10.1097/00003246-200004000-00007

10.1097/00003246-200112000-00005

10.1016/S0261-5614(03)00007-4

10.1097/01.CCM.0000153413.46627.3A

10.1054/clnu.2001.0461

10.1097/00005373-199806000-00016

10.1177/014860719902300124

10.1097/00024382-200405000-00006

10.1016/S0899-9007(02)00847-X

10.1016/S0899-9007(01)00613-X

10.1016/j.burns.2003.09.032

10.1016/j.clnu.2004.04.002

10.1097/01.CCM.0000185643.02676.D3

10.1016/j.trre.2004.01.001

10.1016/j.clnu.2004.01.005

10.1016/j.clnu.2003.12.002

10.1016/j.clnu.2004.01.010

Heimburger DC, 1995, Randomized trial of tolerance and efficacy of a small‐peptide enteral feeding formula versus a whole‐protein formula, Nutrition, 11, 360